common-pharma-interest best-ways-to-increase-productivity-in-lab 
pharmaphorum
NOVEMBER 27, 2022
Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times and higher prices for thousands of products. Here’s how applying automaton in pharmaceutical labs can help address these.
Drug Discovery World
AUGUST 22, 2023
Claire D’Abreau-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines. Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
JANUARY 5, 2021
In other research areas, innovations in the pharmaceutical, medical device and biotech industries will benefit from approaches such as artificial intelligence (AI) and increased digitization. This year will see the rolling out of much-awaited pandemic-ending COVID-19 vaccines. 1. COVID-19 Pandemic: An Evolving Era.
XTalks
OCTOBER 12, 2022
We [Philips Pharma Solutions, formerly BioTel Research] have successfully ran multi-site DCE-MRI trials,” said Edward Ashton, PhD, VP, Oncology Imaging, Philips Pharma Solutions. Magnetic resonance imaging (MRI) has had a part in clinical trials for more than three decades now.
Drug Discovery World
OCTOBER 4, 2022
With 3,633 advanced therapeutical medicinal products (ATMPs) currently in some form of clinical or pre- clinical development, the sector shows no signs of slowing down. Indeed, the first two quarters have shown strong performance compared to 2021, with the number of ATMP trials in Phase I increasing 4%. . billion, compared to $19.9
Drug Discovery World
NOVEMBER 14, 2022
On 4 November 2022, the FDA’s Center for Biologics Evaluation and Research released guidance for the industry for studying multiple versions of a cellular or gene therapy (CGT) product in an early-phase clinical trial in a single disease 1. This guidance finalises the draft guidance of the same title dated September 2021.
XTalks
OCTOBER 1, 2020
To gain insight into the motivations, steps and experiences involved in an academia to industry — or vice versa — transition, Xtalks spoke to several leading scientists and entrepreneurs in pharma and biotech who successfully transitioned from academic positions to leadership roles in industry settings. Key Moments.
Expert insights. Personalized for you.
105 
Let's personalize your content